Company intelligence / Profile preview

Pierrel

Capua, Campania, Italypierrelgroup.com ↗

Ownership: Private
Development stage: Commercial

Overview

Pierrel has over seven decades of experience in oral health pharmaceuticals. Its lead product line includes dental anesthetics based on articaine, mepivacaine, and lidocaine—marketed globally under the Orabloc brand. The company also develops and markets medical devices such as Goccles for oral cancer screening. It holds EMA and FDA approvals for aseptic injectable drug manufacturing. Orabloc has market authorization in at least 37 countries.

Therapeutic areas: OtherOncology
Modalities: Small moleculeMedical device
Industry: Biotech

Partnerships

AstraZenecaDentsply

Beyond the preview

Go deeper on Pierrel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pierrel.

Explore the full profile